Glenn Reicin

Glenn Reicin

Plus aucun poste en cours
61 ans
Finance
Health Technology
Consumer Services

Profil

Glenn M.
Reicin
served as Managing Director at Morgan Stanley & Co. LLC from 1993 to 2008.
Director roles were held at Novasys Medical, Inc. (2009-2013), SpinalMotion, Inc. (2009-2014), and SI-BONE, Inc. (2010-2012).
Managing Director at Skyline Management LLC from 2009 to 2012.
Chief Financial Officer & Treasurer at Sigilon Therapeutics, Inc. from 2019 to 2021.
President of Greyrock Biomedical Advisors Ltd. from 2013 to 2019.
Titles also include Independent Director at Amplitude Healthcare Acquisition Corp., Analyst at Fidelity Management & Research Co. LLC, Senior Vice President at Oppenheimer & Co., Inc., Management Consultant at Bain & Co., Inc., Chief Financial & Operating Officer at Alladapt Immunotherapeutics, Inc., and Chief Financial Officer at Harmony Biosciences Holdings, Inc. in 2026.
Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.

Anciens postes connus de Glenn Reicin

SociétésPosteFin
HARMONY BIOSCIENCES HOLDINGS, INC. Directeur Financier/CFO 16/07/2026
SIGILON THERAPEUTICS, INC. Directeur Financier/CFO 14/06/2021
President 01/05/2019
Directeur/Membre du Conseil 01/01/2014
Directeur/Membre du Conseil 01/01/2013
Voir l'expérience en détail de Glenn Reicin

Formation de Glenn Reicin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

97

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Finance

Finance

Health Services

Health Technology

Health Technology

Finance

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Glenn Reicin
🔇